![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/23/2934893/19782/en/CytoDyn-Engages-Leading-CRO-For-Phase-II-Inflammation-Trial.html
https://www.globenewswire.com/news-release/2024/08/12/2928391/19782/en/CytoDyn-Announces-Completion-of-FDA-Meeting-on-Phase-II-Study-of-Leronlimab-in-Patients-with-Relapsed-Refractory-Microsatellite-Stable-Colorectal-Cancer.html
https://www.globenewswire.com/en/news-release/2024/07/09/2910336/19782/en/CytoDyn-Announces-Settlement-with-Amarex-Clinical-Research-LLC.html
https://www.globenewswire.com/news-release/2024/06/27/2905188/19782/en/CytoDyn-Announces-Start-of-Preclinical-MASH-Study-Results-Expected-in-Fall-2024.html
https://www.globenewswire.com/news-release/2024/05/28/2889026/19782/en/CytoDyn-to-Host-Webcast-to-Provide-Company-Update.html
https://www.globenewswire.com//news-release/2024/02/29/2837977/19782/en/CytoDyn-Announces-FDA-Has-Lifted-Clinical-Hold.html
https://www.fiercebiotech.com/biotech/cytodyn-finally-clears-fda-hold-hiv-program-after-two-years
https://www.globenewswire.com//news-release/2024/02/01/2821970/19782/en/CytoDyn-Announces-Submission-of-Clinical-Protocol-to-FDA-and-Initiation-of-Pre-Clinical-Study-in-Glioblastoma.html
https://www.globenewswire.com/news-release/2024/01/29/2818905/19782/en/CytoDyn-Appoints-Jacob-Lalezari-M-D-as-CEO-Mitchell-Cohen-as-Interim-CFO.html
https://www.globenewswire.com//news-release/2023/12/07/2792877/0/en/Zealand-Pharma-Increases-its-Share-Capital-as-a-Consequence-of-Exercise-of-Employee-Warrants.html